CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net loss for the period	$ (5,102,408)	$ (1,707,358)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	112,277	35,953
Change in operating lease right-of-use assets	23,480	30,945
Changes in operating assets and liabilities:
Prepaid expenses	122,639	61,643
Accounts payable	655,634	364,275
Accrued expenses and other current liabilities	299,203	(9,657)
Operating lease liability	(27,575)	0
Related party payable	(24,244)	47,266
Net cash used in operating activities	(3,940,994)	(1,176,933)
Cash flows from financing activities:
Net proceeds from issuance of common shares and warrants in connection with Regulation A	3,784,101	0
Cash paid for financing costs in connection with SEPA	(25,000)	0
Net cash provided by financing activities	3,759,101	0
Net decrease in cash and cash equivalents during the period	(181,893)	(1,176,933)
Cash and cash equivalents, beginning of the year	4,164,323	1,719,338
Cash and cash equivalents, end of the year	3,982,430	542,405
Supplemental disclosure of non-cash investing and financing activities
Right-of-use assets obtained in exchange for lease liabilities	0	356,805
Receivable for proceeds of warrant exercises	14,000	0
Issuance costs included in accounts payable	95,120	$ 0
Deferred issuance costs on issued shares related to SEPA agreement	$ 300,000